What is the oncologic risk of stem cell treatment for heart disease?

TitleWhat is the oncologic risk of stem cell treatment for heart disease?
Publication TypeJournal Article
Year of Publication2011
AuthorsHatzistergos KE, Blum A, Ince T, Grichnik JM, Hare JM
JournalCirc Res
Volume108
Issue11
Pagination1300-3
Date Published2011 May 27
ISSN1524-4571
KeywordsAnimals, Heart Diseases, Humans, Mesenchymal Stem Cell Transplantation, Neoplasms, Risk Factors
DOI10.1161/CIRCRESAHA.111.246611
Alternate JournalCirc Res
PubMed ID21617132
PubMed Central IDPMC3390911
Grant ListU54-HL0810282 / HL / NHLBI NIH HHS / United States
R01-HL084275 / HL / NHLBI NIH HHS / United States
R01 HL084275 / HL / NHLBI NIH HHS / United States
R01 AG025017 / AG / NIA NIH HHS / United States
R01 HL094849 / HL / NHLBI NIH HHS / United States
U54 HL081028 / HL / NHLBI NIH HHS / United States
R01 HL065455 / HL / NHLBI NIH HHS / United States
P20 HL101443 / HL / NHLBI NIH HHS / United States
Related Faculty: 
Tan Ince, M.D., Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700